These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 22004062

  • 1. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
    Zhang Z, Zhang JY, Wang LF, Wang FS.
    J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL, Kao JH.
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF.
    Antivir Ther; 2006 Mar; 11(6):669-79. PubMed ID: 17310811
    [Abstract] [Full Text] [Related]

  • 6. The immune response induced by hepatitis B virus principal antigens.
    Huang CF, Lin SS, Ho YC, Chen FL, Yang CC.
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
    Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM.
    Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
    [Abstract] [Full Text] [Related]

  • 13. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z, Li B, Xu D, Zhang Z, Zhao JM, Zhou G, Sun Y, Huang L, Fu J, Yang Y, Jin L, Zhang W, Zhao J, Sun Y, Xin S, Wang FS.
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [Abstract] [Full Text] [Related]

  • 14. Innate immune recognition and modulation in hepatitis D virus infection.
    Jung S, Altstetter SM, Protzer U.
    World J Gastroenterol; 2020 Jun 07; 26(21):2781-2791. PubMed ID: 32550754
    [Abstract] [Full Text] [Related]

  • 15. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
    Li TY, Yang Y, Zhou G, Tu ZK.
    World J Gastroenterol; 2019 Jul 21; 25(27):3527-3537. PubMed ID: 31367154
    [Abstract] [Full Text] [Related]

  • 16. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF.
    Semin Liver Dis; 2005 Jul 21; 25 Suppl 1():40-7. PubMed ID: 16103980
    [Abstract] [Full Text] [Related]

  • 17. [The determination of the viral markers of the hepatitis B virus and protein p53 in liver biopsy samples].
    Lörinczi L, Székely E.
    Bacteriol Virusol Parazitol Epidemiol; 1998 Jul 21; 43(3):161-6. PubMed ID: 9932005
    [Abstract] [Full Text] [Related]

  • 18. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B.
    Kim BK, Revill PA, Ahn SH.
    Antivir Ther; 2011 Jul 21; 16(8):1169-86. PubMed ID: 22155900
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus: from diagnosis to treatment.
    Dény P, Zoulim F.
    Pathol Biol (Paris); 2010 Aug 21; 58(4):245-53. PubMed ID: 20580167
    [Abstract] [Full Text] [Related]

  • 20. New insight in the pathobiology of hepatitis B virus infection.
    Dandri M, Locarnini S.
    Gut; 2012 May 21; 61 Suppl 1():i6-17. PubMed ID: 22504921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.